EICHORCondition: Urinary Incontinence · Overactive Bladder · Sponsor: Ipsen
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to provide confirmatory evidence of the safety and efficacy of two Dysport® (AbobotulinumtoxinA) doses (600 units \[U\] and 800 U), compared to placebo in reducing urinary incontinence (UI) in adult subjects treated for neurogenic detrusor overactivity (NDO) due to spinal cord injury (SCI) or multiple sclerosis (MS).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UAB School of Medicine Spain Rehabilitation Center (SRC) | Birmingham, Alabama, United States | — |
| Urological Associates of Southern Arizona, P.C. | Tucson, Arizona, United States | — |
| Atlantic Urology Medical Group | Long Beach, California, United States | — |
| USC Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| UC Davis Medical Center | Sacramento, California, United States | — |
| University of Colorado Denver | Aurora, Colorado, United States | — |
| Women's Health Specialty Care | Farmington, Connecticut, United States | — |
| Gousse Urology - The Bladder Heath and Reconstructive Urology Institute | Miramar, Florida, United States | — |
| The Iowa Clinic, PC | West Des Moines, Iowa, United States | — |
| Chesapeake Urology Associates, PA | Owings Mills, Maryland, United States | — |
| University of Michigan Hospital | Ann Arbor, Michigan, United States | — |
| Weill Cornell Medical College | Denville, New Jersey, United States | — |
+ 69 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02660138